ArticleIndian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India2025
Unveiling Lipid Metabolic Shifts in Different Stages of Oral Submucous Fibrosis: A New Horizon in Predicting Malignant Transformation.
Article in Indian journal of otolaryngology and head and neck surgery : official publication of the Association of Otolaryngologists of India, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Oral Submucous Fibrosis (OSMF) is a chronic, progressive condition linked to areca nut consumption, with a high potential for malignant transformation into oral squamous cell carcinoma (OSCC). Changes in lipid metabolism have been implicated in cancer biology, yet the relationship between lipid profiles and OSMF progression remains underexplored. This study investigates the alterations in serum lipid parameters across different clinical stages of OSMF and their association with malignant transformation. Materials and methods: A cross-sectional study was conducted over 69 OSMF patients, divided into five groups (Stage 1 to 3 and Stage 4a, 4b) based on clinical staging. Serum lipid profiles, including total cholesterol (TC), high-density lipoprotein (HDL), low-density lipoprotein (LDL), very low-density lipoprotein (VLDL), and triglycerides (TG), were analyzed. Statistical analysis was performed using ANOVA and Tukey's post hoc test. Results: Lipid levels (TC, HDL, LDL, VLDL, TG) showed a significant decline from Stage 1 to Stage 4a (p-0.00), followed by a sharp increase in Stage 4b (p-0.00), coinciding with malignant transformation. Particularly, HDL, VLDL, and TG were significantly elevated in Stage 4b compared to earlier stages. Conclusion: Alterations in lipid metabolism (hypolipidemia) were observed from Stage 1 to 4a, with a marked shift (hyperlipidemia) during malignant transformation (Stage 4b). Increased levels of HDL, VLDL, and TG in advanced OSMF stages suggest their potential as predictive biomarkers for malignancy. Further research is required to elucidate the mechanisms linking lipid metabolism with OSMF progression and malignancy, paving the way for targeted therapeutic strategies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.